G. Vlotides

发表

Aspirin inhibits cell viability and mTOR downstream signaling in gastroenteropancreatic and bronchopulmonary neuroendocrine tumor cells.

M. Spampatti, G. Vlotides, G. Spoettl, 2014, World journal of gastroenterology.

Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells

F. Beuschlein, G. Vlotides, J. Maurer, 2013, International journal of oncology.

Combination of 13-Cis retinoic acid and lovastatin: marked antitumor potential in vivo in a pheochromocytoma allograft model in female athymic nude mice.

M. Korbonits, A. Grossman, K. Pacak, 2014, Endocrinology.

Sodium-glucose cotransport inhibitors: mechanisms, metabolic effects and implications for the treatment of diabetic patients with chronic kidney disease.

G. Vlotides, P. Mertens, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Anterior pituitary hormone replacement therapy—a clinical review

G. Vlotides, C. Auernhammer, 2007, Pituitary.

Expression and function of ErbB receptors and ligands in the pituitary.

S. Melmed, M. Greene, G. Vlotides, 2011, Endocrine-related cancer.

Fibroblast growth factor-2 autofeedback regulation in pituitary folliculostellate TtT/GF cells.

S. Melmed, G. Vlotides, S. Ren, 2009, Endocrinology.

Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms.

S. Brand, G. Vlotides, G. Spoettl, 2012, Endocrine-related cancer.

Vitamin D in der Diskussion

G. Vlotides, C. Chatzikyrkou, P. Mertens, 2016 .

Comparative Study of gp130 Cytokine Effects on Corticotroph AtT-20 Cells – Redundancy or Specificity of Neuroimmunoendocrine Modulators?

F. Kopp, G. Senaldi, G. Vlotides, 2004, Neuroimmunomodulation.

Discordant proliferation and differentiation in pituitary tumor-transforming gene-null bone marrow stem cells.

S. Melmed, G. Vlotides, K. Wawrowsky, 2007, American journal of physiology. Cell physiology.

Anti-aging therapy with human growth hormone associated with metastatic colon cancer in a patient with Crohn's colitis.

S. Devlin, S. Melmed, G. Vlotides, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Modulation of monocytic lipopolysaccharide-induced tissue factor expression and tumor necrosis factor alpha release by estrogen and calcitriol.

G. Vlotides, M. Angstwurm, R. Gaertner, 2007, Hormones.

SOCS-1 and SOCS-3 inhibit IFN-α-induced expression of the antiviral proteins 2,5-OAS and MxA

F. Kopp, S. Brand, G. Vlotides, 2004 .

SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA.

F. Kopp, S. Brand, G. Vlotides, 2004, Biochemical and biophysical research communications.

SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29.

S. Brand, S. Eichhorst, G. Vlotides, 2005, Biochemical and biophysical research communications.

Heregulin regulates prolactinoma gene expression.

S. Melmed, G. Vlotides, S. Ren, 2009, Cancer research.

Pituitary tumor-transforming gene: physiology and implications for tumorigenesis.

S. Melmed, G. Vlotides, T. Eigler, 2007, Endocrine reviews.